|
DE59310252D1
(de)
|
1992-02-05 |
2002-01-24 |
Boehringer Ingelheim Pharma |
Neue Amiderivate, ihre Herstellung und Verwendung als Arzneimittel mit LTB4-antagonistischer Wirkung
|
|
ATE219766T1
(de)
|
1993-04-07 |
2002-07-15 |
Otsuka Pharma Co Ltd |
N-acylierte 4-aminopiperidin derivate als aktive bestandteile von peripher gefässerweiternden wikstoffen
|
|
EP0686625B1
(en)
|
1993-12-27 |
1999-05-26 |
Eisai Co., Ltd. |
Anthranilic acid derivative
|
|
GB9500580D0
(en)
|
1995-01-12 |
1995-03-01 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
US5763618A
(en)
|
1995-05-12 |
1998-06-09 |
Konica Corporation |
Manufacturing method of sulfides
|
|
DE19545878A1
(de)
|
1995-12-08 |
1997-06-12 |
Basf Ag |
Pyridylcarbamate, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung
|
|
DE69717268T2
(de)
|
1996-02-22 |
2003-09-04 |
Bristol-Myers Squibb Pharma Co., Wilmington |
M-amidinophenyl-analoga als faktor-xa-inhibitoren
|
|
JP2000507593A
(ja)
|
1996-04-03 |
2000-06-20 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル―タンパク質トランスフェラーゼ阻害剤
|
|
CA2276034A1
(en)
|
1996-12-23 |
1998-07-02 |
Mimi Lifen Quan |
Oxygen or sulfur containing 5-membered heteroaromatics as factor xa inhibitors
|
|
CN1246847A
(zh)
|
1996-12-23 |
2000-03-08 |
杜邦药品公司 |
作为Xa因子抑制剂的含氮杂芳族化合物
|
|
US6187797B1
(en)
|
1996-12-23 |
2001-02-13 |
Dupont Pharmaceuticals Company |
Phenyl-isoxazoles as factor XA Inhibitors
|
|
US6020357A
(en)
|
1996-12-23 |
2000-02-01 |
Dupont Pharmaceuticals Company |
Nitrogen containing heteroaromatics as factor Xa inhibitors
|
|
KR20010013977A
(ko)
|
1997-06-19 |
2001-02-26 |
블레어 큐. 퍼거슨 |
중성 ｐ1 특이성 기를 갖는 인자 ｘａ의 억제제
|
|
US6339099B1
(en)
|
1997-06-20 |
2002-01-15 |
Dupont Pharmaceuticals Company |
Guanidine mimics as factor Xa inhibitors
|
|
DE69826487T2
(de)
|
1997-07-30 |
2005-12-01 |
Wyeth |
Trizyclische vasopressin-agonisten
|
|
BR9811559A
(pt)
|
1997-07-30 |
2000-09-12 |
American Home Prod |
Agonistas tricìclicos de vasopressina
|
|
US6511974B1
(en)
|
1997-07-30 |
2003-01-28 |
Wyeth |
Tricyclic vasopressin agonists
|
|
AU3665199A
(en)
|
1998-04-29 |
1999-11-16 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of impdh enzyme
|
|
AU3791699A
(en)
|
1998-05-12 |
1999-11-29 |
American Home Products Corporation |
Naphtho{2,3-b}heteroar-4-yl derivatives
|
|
US6121271A
(en)
|
1998-05-12 |
2000-09-19 |
American Home Products Corporation |
Naphtho[2,3-B]heteroar-4-yl derivatives
|
|
JP2000109465A
(ja)
*
|
1998-08-05 |
2000-04-18 |
Nippon Soda Co Ltd |
フェニルピラゾ―ル化合物、製法及び抗高脂血症薬
|
|
AU1707700A
(en)
|
1998-10-29 |
2000-05-22 |
Bristol-Myers Squibb Company |
Novel inhibitors of impdh enzyme
|
|
WO2000029399A1
(en)
|
1998-11-12 |
2000-05-25 |
Boehringer Ingelheim (Canada) Ltd. |
Antiherpes compounds
|
|
CA2358894A1
(en)
|
1999-02-04 |
2000-08-10 |
American Home Products Corporation |
Tricyclic pyridine n-oxides vasopressin agonists
|
|
JP2000256358A
(ja)
|
1999-03-10 |
2000-09-19 |
Yamanouchi Pharmaceut Co Ltd |
ピラゾール誘導体
|
|
NZ515086A
(en)
|
1999-04-28 |
2003-10-31 |
Aventis Pharma Gmbh |
Di-aryl acid derivatives as PPAR receptor ligands
|
|
CN1391476A
(zh)
|
1999-09-27 |
2003-01-15 |
美国氰胺公司 |
血管升压素激动剂制剂和方法
|
|
WO2001051456A2
(en)
|
2000-01-13 |
2001-07-19 |
Tularik Inc. |
Antibacterial agents
|
|
WO2001068605A1
(en)
|
2000-03-13 |
2001-09-20 |
Pharmacia Corporation |
Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
|
|
MY138097A
(en)
|
2000-03-22 |
2009-04-30 |
Du Pont |
Insecticidal anthranilamides
|
|
WO2002000651A2
(en)
|
2000-06-27 |
2002-01-03 |
Bristol-Myers Squibb Pharma Company |
Factor xa inhibitors
|
|
DE10063008A1
(de)
|
2000-12-16 |
2002-06-20 |
Merck Patent Gmbh |
Carbonsäureamidderivate
|
|
AU2002248432A1
(en)
|
2001-02-14 |
2002-08-28 |
Sankyo Company, Limited |
Oxazole derivatives, their preparation and their use as cytokine inhibitors
|
|
PL364660A1
(en)
|
2001-03-05 |
2004-12-13 |
E.I.Du Pont De Nemours And Company |
Heterocyclic diamide invertebrate pest control agents
|
|
DE10110749A1
(de)
|
2001-03-07 |
2002-09-12 |
Bayer Ag |
Substituierte Aminodicarbonsäurederivate
|
|
DE10111842A1
(de)
|
2001-03-13 |
2002-09-19 |
Boehringer Ingelheim Pharma |
Antithrombotische Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel
|
|
EP1394154A4
(en)
|
2001-03-23 |
2005-05-18 |
Takeda Pharmaceutical |
FIVE-GLASS HETEROCYCLIC ALKANIC ACID DERIVATIVE
|
|
US6890915B2
(en)
|
2001-05-25 |
2005-05-10 |
Bristol-Myers Squibb Pharma Company |
Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
|
|
DE10130374A1
(de)
|
2001-06-23 |
2003-01-02 |
Boehringer Ingelheim Pharma |
Substituierte N-Acyl-anilinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
BR0210609A
(pt)
|
2001-06-28 |
2004-07-20 |
Smithkline Beecham Plc |
Derivados de amina cìclica n-aroila como antagonistas do receptor da orexina
|
|
GB0115862D0
(en)
|
2001-06-28 |
2001-08-22 |
Smithkline Beecham Plc |
Compounds
|
|
WO2003004474A1
(en)
|
2001-07-06 |
2003-01-16 |
Syngenta Participations Ag |
Pesticidally active aminoacetonitriles
|
|
ATE491701T1
(de)
|
2001-08-03 |
2011-01-15 |
Vertex Pharma |
Von pyrazol abgeleitete kinaseinhibitoren und deren verwendung
|
|
GB0124463D0
(en)
|
2001-10-11 |
2001-12-05 |
Smithkline Beecham Plc |
Compounds
|
|
SE0103644D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic isoquinoline compounds
|
|
US6984735B2
(en)
|
2001-12-03 |
2006-01-10 |
Wyeth |
Process for making an aldehyde
|
|
AU2003220401A1
(en)
|
2002-03-18 |
2003-10-08 |
Bristol-Myers Squibb Company |
Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases
|
|
EP1487796A4
(en)
|
2002-03-28 |
2005-11-16 |
Neurogen Corp |
SUBSTITUTED BIARYLAMIDES AS MODULATORS OF THE C5A RECEPTOR
|
|
WO2004000788A1
(en)
|
2002-06-19 |
2003-12-31 |
Bristol-Myers Squibb Company |
Ureido-substituted aniline compounds useful as serine protease inhibitors
|
|
US20040044041A1
(en)
|
2002-08-06 |
2004-03-04 |
Kuduk Scott D. |
2-(Biarylalkyl)amino-3-(cyanoalkanoylamino)pyridine derivatives
|
|
EP1534680B1
(en)
|
2002-08-14 |
2012-02-22 |
Pharmaco Investments, Inc. |
Prenylation inhibitors and methods of their synthesis and use
|
|
AU2003282920A1
(en)
|
2002-10-04 |
2004-05-04 |
Bristol-Myers Squibb Company |
Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
|
|
US20040082641A1
(en)
|
2002-10-28 |
2004-04-29 |
Rytved Klaus Asger |
Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases
|
|
CA2505361A1
(en)
|
2002-11-11 |
2004-05-27 |
Bayer Healthcare Ag |
Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
|
|
JP2004161716A
(ja)
|
2002-11-15 |
2004-06-10 |
Takeda Chem Ind Ltd |
Ｊｎｋ阻害剤
|
|
US20040248850A1
(en)
|
2003-02-11 |
2004-12-09 |
Kemia, Inc. |
Compounds for the treatment of HIV infection
|
|
DE10306250A1
(de)
|
2003-02-14 |
2004-09-09 |
Aventis Pharma Deutschland Gmbh |
Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
BRPI0409447A
(pt)
|
2003-04-14 |
2006-04-18 |
Inst For Pharm Discovery Inc |
ácidos fenilalcanóicos substituìdos
|
|
WO2005000813A1
(en)
|
2003-05-30 |
2005-01-06 |
Imclone Systems Incorporated |
Heteroarylamino-phenylketone derivatives and their use as kinase inhibitors
|
|
EP1650206A4
(en)
|
2003-08-01 |
2006-12-20 |
Nippon Soda Co |
PHENYLAZOLE COMPOUNDS, PROCESS FOR THEIR PRODUCTION AND ANTIOXIDANTS
|
|
US7485658B2
(en)
|
2003-08-21 |
2009-02-03 |
Osi Pharmaceuticals, Inc. |
N-substituted pyrazolyl-amidyl-benzimidazolyl c-Kit inhibitors
|
|
EP1664032B1
(en)
|
2003-08-21 |
2008-11-05 |
OSI Pharmaceuticals, Inc. |
N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
|
|
EP1663204B1
(en)
|
2003-08-29 |
2014-05-07 |
Exelixis, Inc. |
C-kit modulators and methods of use
|
|
WO2005023809A1
(en)
|
2003-09-10 |
2005-03-17 |
Virochem Pharma Inc. |
Spiro compounds and methods for the modulation of chemokine receptor activity
|
|
US7211671B2
(en)
|
2003-10-01 |
2007-05-01 |
Bristol Myers Squibb Company |
Substituted 1,3-dihydro-imidazol-2-one and 1,3-dihydro-imidazol-2-thione derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
|
|
CA2541458C
(en)
|
2003-10-08 |
2011-09-20 |
Eli Lilly And Company |
Pyrrole and pyrazole derivatives as potentiators of glutamate receptors
|
|
WO2005039494A2
(en)
|
2003-10-21 |
2005-05-06 |
Message Pharmaceuticals, Inc. |
Inhibitors of rnase p proteins as antibacterial compounds
|
|
WO2005074643A2
(en)
|
2004-01-30 |
2005-08-18 |
Smithkline Beecham Corporation |
Benzamide compounds useful as rock inhibitors
|
|
EP1574502A1
(en)
|
2004-03-08 |
2005-09-14 |
Novartis AG |
Use of pyrimidine compounds in the preparation of parasiticides
|
|
WO2006028963A2
(en)
|
2004-09-03 |
2006-03-16 |
Celgene Corporation |
Substituted heterocyclic compounds and uses thereof
|
|
TW200630327A
(en)
|
2004-10-28 |
2006-09-01 |
Inst For Pharm Discovery Inc |
Substituted phenylalkanoic acids
|
|
US20080045492A1
(en)
|
2004-12-21 |
2008-02-21 |
Coleman Paul J |
Mitotic Kinesin Inhibitors
|
|
US8329703B2
(en)
|
2005-02-15 |
2012-12-11 |
Xtl Biopharmaceuticals Ltd. |
Pyrazole compounds
|
|
US20060223837A1
(en)
|
2005-03-24 |
2006-10-05 |
Ellen Codd |
Biaryl derived amide modulators of vanilloid VR1 receptor
|
|
FR2887548B1
(fr)
|
2005-06-27 |
2007-09-21 |
Sanofi Aventis Sa |
Derives de 4,5-diarylpyrrole, leur preparation et leur application en therapeutique
|
|
US8703805B2
(en)
|
2005-06-27 |
2014-04-22 |
Exelixis Patent Company Llc |
Modulators of LXR
|
|
FR2888237B1
(fr)
|
2005-07-08 |
2007-08-31 |
Sanofi Aventis Sa |
Derives de n-[(4,5-diphenylpyrimidin-2-yl)methyl] amine, leur preparation et leur application en therapeutique
|
|
AR057450A1
(es)
|
2005-07-12 |
2007-12-05 |
Sanofi Aventis |
Derivados de n-[(1,2-difenil-1h-imidazol-4- il)metil]amina su preparacion y su aplicacion en terapeutica
|
|
WO2007024922A1
(en)
|
2005-08-23 |
2007-03-01 |
Irm Llc |
Immunosuppressant compounds and compositions
|
|
US7906652B2
(en)
|
2005-11-28 |
2011-03-15 |
Merck Sharp & Dohme Corp. |
Heterocycle-substituted 3-alkyl azetidine derivatives
|
|
FR2894579B1
(fr)
|
2005-12-12 |
2008-01-18 |
Sanofi Aventis Sa |
Derives diaryltriazolmethylamine, leur preparation et leur application en therapeutique.
|
|
FR2894578B1
(fr)
|
2005-12-12 |
2008-02-01 |
Sanofi Aventis Sa |
Derives heterocycliques, leur preparation et leur application en therapeutique.
|
|
US20090042926A1
(en)
|
2005-12-20 |
2009-02-12 |
Jason Imbriglio |
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
|
|
SI1962830T1
(sl)
|
2005-12-23 |
2013-07-31 |
Glaxosmithkline Llc |
Azaindolni inhibitorji kinaz Aurora
|
|
WO2007098169A1
(en)
|
2006-02-21 |
2007-08-30 |
Amgen Inc. |
Cinnoline derivatives as phosphodiesterase 10 inhibitors
|
|
AU2012200157B2
(en)
|
2006-05-25 |
2014-08-21 |
Synta Pharmaceuticals Corp. |
Method for treating proliferative disorders associated with protooncogene products
|
|
WO2007146230A2
(en)
|
2006-06-14 |
2007-12-21 |
Merck & Co., Inc. |
Non-nucleoside reverse transcriptase inhibitors
|
|
US9108948B2
(en)
|
2006-06-23 |
2015-08-18 |
Abbvie Inc. |
Cyclopropyl amine derivatives
|
|
RU2424233C2
(ru)
|
2006-06-29 |
2011-07-20 |
Ф.Хоффманн-Ля Рош Аг |
Производные бензимидазола, методы их получения, применение их в качестве агонистов фарнезоид-х-рецептора (fxr) и содержащие их фармацевтические препараты
|
|
PE20080401A1
(es)
|
2006-07-07 |
2008-06-23 |
Boehringer Ingelheim Int |
DERIVADOS DE HETEROARIL-FENIL SUSTITUIDOS COMO INHIBIDORES DE B-Raf-QUINASAS
|
|
WO2008016643A2
(en)
|
2006-08-01 |
2008-02-07 |
Cytokinetics, Incorporated |
Certain chemical entities, compositions, and methods
|
|
FR2904827B1
(fr)
|
2006-08-11 |
2008-09-19 |
Sanofi Aventis Sa |
Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antiganistes des recepteurs a l'urotensine ii
|
|
JP2010502660A
(ja)
|
2006-09-06 |
2010-01-28 |
エフ．ホフマン−ラ ロシュ アーゲー |
プロテインキナーゼインヒビターとしてのヘテロアリール誘導体
|
|
WO2008057246A2
(en)
|
2006-10-26 |
2008-05-15 |
Synta Pharmaceuticals Corp. |
Method for treating inflammatory disorders
|
|
WO2008064317A1
(en)
|
2006-11-22 |
2008-05-29 |
University Of Medicine And Dentistry Of New Jersey |
Lipophilic opioid receptor active compounds
|
|
WO2008064318A2
(en)
|
2006-11-22 |
2008-05-29 |
University Of Medicine And Dentistry Of New Jersey |
Peripheral opioid receptor active compounds
|
|
WO2008064310A2
(en)
|
2006-11-22 |
2008-05-29 |
University Of Medicine And Dentistry Of New Jersey |
Mixed opioid receptor active compounds
|
|
DK2354124T3
(da)
|
2006-12-19 |
2013-03-11 |
Hoffmann La Roche |
Heteroarylpyrrolidinyl og piperidinylketonderivater
|
|
CA2674237C
(en)
|
2006-12-28 |
2015-11-24 |
Rigel Pharmaceuticals, Inc. |
N-substituted-heterocycloalkyloxybenzamide compounds and methods of use
|
|
FR2911136B1
(fr)
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Derives de n-(4-cyano-1h-pyrazol-3-yl)methylamine substitues leur preparation et leur application en therapeutique.
|
|
WO2008088692A2
(en)
|
2007-01-12 |
2008-07-24 |
Merck & Co., Inc. |
Spirochromanon derivatives
|
|
TW200838516A
(en)
|
2007-01-31 |
2008-10-01 |
Merck & Co Inc |
Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
|
|
JP2008195655A
(ja)
|
2007-02-14 |
2008-08-28 |
Kitasato Institute |
糖尿病白内障の治療剤
|
|
WO2008137102A2
(en)
|
2007-05-04 |
2008-11-13 |
Torreypines Therapeutics, Inc. |
Methods of modulating amyloid beta and compounds useful therefor
|
|
EP1992625A1
(en)
|
2007-05-16 |
2008-11-19 |
Sanofi-Aventis |
Arylamide pyrimidone compounds
|
|
CA2687306A1
(en)
|
2007-05-18 |
2008-11-27 |
Bayer Schering Pharma Aktiengesellschaft |
Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
|
|
JP4881476B2
(ja)
|
2007-05-23 |
2012-02-22 |
メルク・シャープ・エンド・ドーム・コーポレイション |
ピリジルピペリジン・オレキシン受容体アンタゴニスト
|
|
AR066834A1
(es)
|
2007-06-06 |
2009-09-16 |
Janssen Pharmaceutica Nv |
Espirobenzoazepanos como antagonistas de vasopresina, composiciones farmaceuticas que los contienen, proceso de preparacion y usos para el tratamiento de afecciones cardiacas, renales y del sistema nervioso central.
|
|
EP2002838A1
(de)
|
2007-06-13 |
2008-12-17 |
Bayer Schering Pharma AG |
Verwendung von Aryl/Hetarylamid-Derivaten als Modulatoren des EP2-Rezeptors
|
|
EA200901652A1
(ru)
|
2007-06-15 |
2010-06-30 |
Басф Се |
Способ получения дифторметилзамещённых пиразоловых соединений
|
|
US20100240657A1
(en)
|
2007-07-02 |
2010-09-23 |
Boehringer Ingelheim International Gmbh |
Chemical compounds
|
|
US8148380B2
(en)
|
2007-07-23 |
2012-04-03 |
Crestone, Inc. |
Antibacterial amide and sulfonamide substituted heterocyclic urea compounds
|
|
CA2696113A1
(en)
|
2007-08-10 |
2009-04-02 |
Burnham Institute For Medical Research |
Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof
|
|
US8445686B2
(en)
|
2007-08-27 |
2013-05-21 |
Abbvie Inc. |
4-(4-pyridinyl)-benzamides and their use as rock activity modulators
|
|
TW200920357A
(en)
|
2007-09-10 |
2009-05-16 |
Curis Inc |
HSP90 inhibitors containing a zinc binding moiety
|
|
WO2009036051A1
(en)
|
2007-09-10 |
2009-03-19 |
Curis, Inc. |
Bcl-2 inhibitors containing a zinc binding moiety
|
|
KR20090033583A
(ko)
|
2007-10-01 |
2009-04-06 |
주식회사 엘지생명과학 |
글라이신 아릴 아마이드를 포함하는 신규한베타-세크리타제 저해용 화합물
|
|
EP2212282B1
(en)
|
2007-10-17 |
2011-09-21 |
Sanofi |
Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
|
|
TWI440638B
(zh)
|
2007-10-30 |
2014-06-11 |
Otsuka Pharma Co Ltd |
雜環化合物及其藥學組成物
|
|
WO2009061676A2
(en)
|
2007-11-06 |
2009-05-14 |
Amira Pharmaceuticals, Inc. |
Antagonists of pgd2 receptors
|
|
EP2227471A1
(en)
|
2007-12-11 |
2010-09-15 |
Schering Corporation |
Gamma secretase modulators
|
|
WO2009079008A1
(en)
*
|
2007-12-19 |
2009-06-25 |
Yangbo Feng |
Benzopyrans and analogs as rho kinase inhibitors
|
|
US20110038835A1
(en)
*
|
2007-12-21 |
2011-02-17 |
The Scripps Research Institute |
Anilides and analogs as rho kinase inhibitors
|
|
CN101538245B
(zh)
|
2008-03-18 |
2011-02-16 |
中国科学院上海药物研究所 |
一类哒嗪酮类化合物及其制备方法和制备药物的用途
|
|
TW201000107A
(en)
|
2008-04-09 |
2010-01-01 |
Infinity Pharmaceuticals Inc |
Inhibitors of fatty acid amide hydrolase
|
|
EP2269993B1
(en)
|
2008-04-23 |
2013-02-27 |
Kyowa Hakko Kirin Co., Ltd. |
2-aminoquinazoline derivative
|
|
CN102088855A
(zh)
|
2008-05-08 |
2011-06-08 |
百时美施贵宝公司 |
2-芳基甘氨酰胺衍生物
|
|
CN101597278B
(zh)
|
2008-06-04 |
2013-04-17 |
中国中化股份有限公司 |
酰胺类化合物及其制备与应用
|
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
|
TWI546290B
(zh)
|
2008-06-27 |
2016-08-21 |
賽基艾維洛米斯研究股份有限公司 |
雜芳基化合物及其用途
|
|
US8623238B2
(en)
|
2008-06-27 |
2014-01-07 |
Transitions Optical, Inc. |
Mesogenic stabilizers
|
|
WO2010036316A1
(en)
*
|
2008-09-24 |
2010-04-01 |
Yangbo Feng |
Urea and carbamate compounds and analogs as kinase inhibitors
|
|
EP2350006A1
(en)
|
2008-10-01 |
2011-08-03 |
Synta Pharmaceuticals Corp. |
Compounds for inflammation and immune-related uses
|
|
JP5701213B2
(ja)
|
2008-10-10 |
2015-04-15 |
インスティチュート オブ ファーマコロジー アンド トキシコロジー アカデミー オブ ミリタリー メディカル サイエンシズ ピー．エル．エー．チャイナ |
新規なドーパミンｄ３受容体リガンド、その調製及び使用
|
|
WO2010077624A1
(en)
|
2008-12-09 |
2010-07-08 |
Merck Sharp & Dohme Corp. |
Biaryl carboxamides
|
|
JP2012512877A
(ja)
|
2008-12-18 |
2012-06-07 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
セロトニン５−ｈｔ２ｂ受容体阻害剤
|
|
WO2010075290A1
(en)
|
2008-12-22 |
2010-07-01 |
President And Fellows Of Harvard College |
Unsaturated heterocyclic inhibitors of necroptosis
|
|
WO2010093849A2
(en)
|
2009-02-13 |
2010-08-19 |
Amgen Inc. |
Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions
|
|
JP5688918B2
(ja)
|
2009-04-28 |
2015-03-25 |
大塚製薬株式会社 |
医薬組成物
|
|
WO2010129848A2
(en)
|
2009-05-08 |
2010-11-11 |
Takeda Pharmaceutical Company Limited |
2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamides
|
|
BRPI1011247A2
(pt)
|
2009-06-09 |
2016-06-21 |
California Capital Equity Llc |
derivados de isoquinolina, quinolina e quinazolina como inibidores de sinalização de hedgehog
|
|
AR077033A1
(es)
|
2009-06-11 |
2011-07-27 |
Hoffmann La Roche |
Compuestos inhibidores de las quinasas de janus y su uso en el tratamiento de enfermedades inmunologicas
|
|
CA2773561A1
(en)
|
2009-09-14 |
2011-03-17 |
Phusis Therapeutics Inc. |
Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
|
|
US20110082098A1
(en)
|
2009-09-30 |
2011-04-07 |
University Of Kansas |
Novobiocin analogues and treatment of polycystic kidney disease
|
|
US8993612B2
(en)
|
2009-10-08 |
2015-03-31 |
Rhizen Pharmaceuticals Sa |
Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
|
|
US8377970B2
(en)
|
2009-10-08 |
2013-02-19 |
Rhizen Pharmaceuticals Sa |
Modulators of calcium release-activated calcium channel
|
|
EP2499140A1
(en)
|
2009-11-10 |
2012-09-19 |
Pfizer Inc. |
N2-pyrazolospiroketone acetyl-coa carboxylase inhibitors
|
|
WO2011058474A1
(en)
|
2009-11-10 |
2011-05-19 |
Pfizer Inc. |
N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
|
|
US8394858B2
(en)
|
2009-12-03 |
2013-03-12 |
Novartis Ag |
Cyclohexane derivatives and uses thereof
|
|
WO2011073376A1
(en)
|
2009-12-18 |
2011-06-23 |
Euroscreen S.A. |
Pyrrolidine or thiazolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disordersas as agonists of g- protein coupled receptor 43 (gpr43)
|
|
JP2013047188A
(ja)
|
2009-12-24 |
2013-03-07 |
Nippon Chemiphar Co Ltd |
Ｇｐｒ１１９作動薬
|
|
WO2011088031A1
(en)
|
2010-01-13 |
2011-07-21 |
Glaxosmithkline Llc |
Compounds and methods
|
|
CN103221047B
(zh)
|
2010-01-13 |
2014-12-17 |
坦颇罗制药股份有限公司 |
化合物和方法
|
|
JP2013517273A
(ja)
|
2010-01-13 |
2013-05-16 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
化合物および方法
|
|
KR20120130104A
(ko)
|
2010-02-01 |
2012-11-28 |
닛뽕 케미파 가부시키가이샤 |
Ｇｐｒ119 작동약
|
|
JP5850321B2
(ja)
|
2010-02-10 |
2016-02-03 |
公立大学法人横浜市立大学 |
神経選択的転写抑制因子ＮＲＳＦに特異的に結合するｍＳｉｎ３Ｂに結合する化合物の利用
|
|
WO2011106632A1
(en)
|
2010-02-26 |
2011-09-01 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
|
EP2545042A1
(en)
|
2010-03-11 |
2013-01-16 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis c
|
|
US8354410B2
(en)
|
2010-03-11 |
2013-01-15 |
Bristol-Meyers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US8598164B2
(en)
|
2010-05-06 |
2013-12-03 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
|
|
WO2011156557A2
(en)
|
2010-06-11 |
2011-12-15 |
Thomas James B |
Compounds active at the neurotensin receptor
|
|
US8697911B2
(en)
|
2010-07-07 |
2014-04-15 |
Boehringer Ingelheim International Gmbh |
Rho kinase inhibitors
|
|
US9079880B2
(en)
|
2010-07-07 |
2015-07-14 |
Boehringer Ingelheim International Gmbh |
Rho kinase inhibitors
|
|
EP2606051B1
(en)
|
2010-08-20 |
2016-10-05 |
Hutchison Medipharma Limited |
Pyrrolopyrimidine compounds and uses thereof
|
|
WO2012040444A2
(en)
|
2010-09-24 |
2012-03-29 |
Bristol-Myers Squibb Company |
Treatment of patients with incipient alzheimer's disease
|
|
EP2627324A4
(en)
|
2010-10-11 |
2014-05-07 |
Univ Leland Stanford Junior |
SUBSTITUTED BENZAMIDES AND USES THEREOF
|
|
CN102451178A
(zh)
|
2010-10-29 |
2012-05-16 |
中国科学院上海药物研究所 |
二氢呋喃-2-酮类化合物在制备抗糖尿病及糖脂代谢药物中的用途
|
|
US20120129843A1
(en)
|
2010-11-18 |
2012-05-24 |
Yan Zhang |
Pyridyl-thiazolyl inhibitors of pro-matrix metalloproteinase activation
|
|
US8653270B2
(en)
|
2010-11-22 |
2014-02-18 |
Allergan, Inc. |
Compounds as receptor modulators with therapeutic utility
|
|
EP2457900A1
(en)
|
2010-11-25 |
2012-05-30 |
Almirall, S.A. |
New pyrazole derivatives having CRTh2 antagonistic behaviour
|
|
JP5946775B2
(ja)
|
2010-12-01 |
2016-07-06 |
日産化学工業株式会社 |
ピラゾール化合物による造血幹細胞の製造方法
|
|
WO2012074067A1
(ja)
|
2010-12-01 |
2012-06-07 |
日産化学工業株式会社 |
多発性骨髄腫の治療効果を有するピラゾール化合物
|
|
EA201390821A1
(ru)
|
2010-12-07 |
2013-10-30 |
Амира Фармасьютикалс, Инк. |
Антагонисты рецепторов лизофосфатидной кислоты и их применение
|
|
GB201021104D0
(en)
|
2010-12-13 |
2011-01-26 |
Univ Leuven Kath |
Novel compounds for the treatment of neurodegenerative diseases
|
|
MX355907B
(es)
|
2011-02-02 |
2018-05-04 |
Vertex Pharma |
Pirrolopirazina-piperidina espirociclica-amidas como moduladores de canales de ionicos.
|
|
GB201104267D0
(en)
|
2011-03-14 |
2011-04-27 |
Cancer Rec Tech Ltd |
Pyrrolopyridineamino derivatives
|
|
ES2608967T3
(es)
|
2011-03-28 |
2017-04-17 |
Mei Pharma, Inc. |
(Aralquilamino sustituido en alfa y heteroarilalquilamino)pirimidinil y 1,3,5-triazinil benzimidazoles, composiciones farmacéuticas que los contienen, y estos compuestos para usar en el tratamiento de enfermedades proliferativas
|
|
WO2012135697A2
(en)
|
2011-03-30 |
2012-10-04 |
H. Lee Moffitt Cancer Center & Research Institute Inc. |
Novel rho kinase inhibitors and methods of use
|
|
GB201107223D0
(en)
|
2011-04-29 |
2011-06-15 |
Amakem Nv |
Novel rock inhibitors
|
|
AP3308A
(en)
|
2011-05-26 |
2015-06-30 |
Tfchem |
Family of aryl, heteroaryl, O-aryl and O-heteroaryl carbasugars
|
|
EP2714688B1
(en)
|
2011-05-26 |
2016-02-24 |
Daiichi Sankyo Company, Limited |
Heterocyclic compounds as protein kinase inhibitors
|
|
WO2012166389A1
(en)
|
2011-05-31 |
2012-12-06 |
Theravance, Inc. |
Neprilysin inhibitors
|
|
BR112014000499A2
(pt)
|
2011-07-12 |
2017-01-10 |
Hoffmann La Roche |
compostos de quinolona de aminometila
|
|
WO2013018526A1
(ja)
|
2011-07-29 |
2013-02-07 |
日本ゼオン株式会社 |
光学異方体の波長分散調整方法及び重合性組成物
|
|
WO2013067248A1
(en)
|
2011-11-04 |
2013-05-10 |
Vertex Pharmaceuticals Incorporated |
Benzoxazines as modulators of ion channels
|
|
AU2013305759C1
(en)
|
2012-08-23 |
2018-01-18 |
Janssen Biopharma, Inc. |
Compounds for the treatment of paramoxyvirus viral infections
|
|
WO2014079850A1
(en)
|
2012-11-23 |
2014-05-30 |
F. Hoffmann-La Roche Ag |
Substituted heterocyclic derivatives
|
|
JP6488239B2
(ja)
|
2013-01-18 |
2019-03-20 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
Ｒｏｃｋ阻害剤としてのフタラジノンおよびイソキノリノン
|
|
AR094929A1
(es)
|
2013-02-28 |
2015-09-09 |
Bristol Myers Squibb Co |
Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
|
|
US9914740B2
(en)
|
2013-07-02 |
2018-03-13 |
Bristol-Myers Squibb Company |
Tricyclic pyrido-carboxamide derivatives as rock inhibitors
|
|
EP3016950B1
(en)
|
2013-07-02 |
2017-06-07 |
Bristol-Myers Squibb Company |
Tricyclic pyrido-carboxamide derivatives as rock inhibitors
|
|
MX2016008842A
(es)
|
2014-01-20 |
2016-11-08 |
Hoffmann La Roche |
Derivados de n-fenil-lactama capaces de estimular la neurogenesis y su uso en el tratamiento de trastornos neurologicos.
|